Cargando…

Case report of a very rare primary malignant bone tumor: Mixed type maxillary osteosarcoma

Osteosarcoma (OS) is the most common primary malignant bone tumor, accounting for approximately 20% of all primary bone malignancies. OS affects 2-4.8 in 1,000,000 individuals annually and is more common in men than women (1.5:1 ratio). The most common locations include the femur (42%), the tibia (1...

Descripción completa

Detalles Bibliográficos
Autores principales: Margiono, Eko Ardianto, Andreani, Sri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989315/
https://www.ncbi.nlm.nih.gov/pubmed/36895897
http://dx.doi.org/10.1016/j.radcr.2023.01.104
_version_ 1784901745446486016
author Margiono, Eko Ardianto
Andreani, Sri
author_facet Margiono, Eko Ardianto
Andreani, Sri
author_sort Margiono, Eko Ardianto
collection PubMed
description Osteosarcoma (OS) is the most common primary malignant bone tumor, accounting for approximately 20% of all primary bone malignancies. OS affects 2-4.8 in 1,000,000 individuals annually and is more common in men than women (1.5:1 ratio). The most common locations include the femur (42%), the tibia (19%), and the humerus (10%), whereas other potential sites include the skull or jaw (8%) and the pelvis (8%). We report a very rare case in a 48-year-old female who presented with swelling of the left cheek accompanied by palpable solid mass, with the final diagnosis of mixed type maxillary OS was confirmed from a surgical biopsy.
format Online
Article
Text
id pubmed-9989315
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99893152023-03-08 Case report of a very rare primary malignant bone tumor: Mixed type maxillary osteosarcoma Margiono, Eko Ardianto Andreani, Sri Radiol Case Rep Case Report Osteosarcoma (OS) is the most common primary malignant bone tumor, accounting for approximately 20% of all primary bone malignancies. OS affects 2-4.8 in 1,000,000 individuals annually and is more common in men than women (1.5:1 ratio). The most common locations include the femur (42%), the tibia (19%), and the humerus (10%), whereas other potential sites include the skull or jaw (8%) and the pelvis (8%). We report a very rare case in a 48-year-old female who presented with swelling of the left cheek accompanied by palpable solid mass, with the final diagnosis of mixed type maxillary OS was confirmed from a surgical biopsy. Elsevier 2023-02-27 /pmc/articles/PMC9989315/ /pubmed/36895897 http://dx.doi.org/10.1016/j.radcr.2023.01.104 Text en © 2023 The Authors. Published by Elsevier Inc. on behalf of University of Washington. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Margiono, Eko Ardianto
Andreani, Sri
Case report of a very rare primary malignant bone tumor: Mixed type maxillary osteosarcoma
title Case report of a very rare primary malignant bone tumor: Mixed type maxillary osteosarcoma
title_full Case report of a very rare primary malignant bone tumor: Mixed type maxillary osteosarcoma
title_fullStr Case report of a very rare primary malignant bone tumor: Mixed type maxillary osteosarcoma
title_full_unstemmed Case report of a very rare primary malignant bone tumor: Mixed type maxillary osteosarcoma
title_short Case report of a very rare primary malignant bone tumor: Mixed type maxillary osteosarcoma
title_sort case report of a very rare primary malignant bone tumor: mixed type maxillary osteosarcoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989315/
https://www.ncbi.nlm.nih.gov/pubmed/36895897
http://dx.doi.org/10.1016/j.radcr.2023.01.104
work_keys_str_mv AT margionoekoardianto casereportofaveryrareprimarymalignantbonetumormixedtypemaxillaryosteosarcoma
AT andreanisri casereportofaveryrareprimarymalignantbonetumormixedtypemaxillaryosteosarcoma